Cargando…

How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile?

Chile has a passive surveillance system of adverse events following immunization (AEFI) that allows monitoring and evaluating the safety profile of the vaccines administered. Between 2018 and 2019, the National Immunization Program (NIP) changed from a pentavalent whole-cell pertussis vaccine (wP) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguirre-Boza, Francisca, San Martín P, Pamela, Valenzuela B, María Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828142/ https://www.ncbi.nlm.nih.gov/pubmed/34495813 http://dx.doi.org/10.1080/21645515.2021.1965424

Ejemplares similares

Is diphtheria-tetanus-pertussis (DTP) associated with increased female mortality? A meta-analysis testing the hypotheses of sex-differential non-specific effects of DTP vaccine
por: Aaby, Peter, et al.
Publicado: (2016)

Implementation and adherence of routine pertussis vaccination (DTP) in a low-resource urban birth cohort
por: Gunning, Christian E, et al.
Publicado: (2020)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India
por: Bakhache, Pierre, et al.
Publicado: (2021)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Comparative analysis of the intracerebral mouse protection test and serological method for potency assays of pertussis component in DTP vaccine
por: Matos, Denise Cristina Souza, et al.
Publicado: (2012)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

Diseño para la autoedición (DTP) /
por: Collier, David, 1966-
Publicado: (1992)

Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural Bangladesh
por: Aaby, Peter, et al.
Publicado: (2017)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
Publicado: (2021)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

DTP: the complete guide to corporate desktop publishing
por: Jones, Robert
Publicado: (1988)

Oral Diazepam in Febrile Seizures Following Acellular Pertussis Vaccination
por: Ghazavi, Mohammadreza, et al.
Publicado: (2019)

Pertussis outbreak in Polish shooters with adverse event analysis
por: Skrzypiec-Spring, Monika, et al.
Publicado: (2017)

Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
por: Dubois, Violaine, et al.
Publicado: (2021)

Acellular pertussis vaccine efficacy: An updated systematic review and meta –analysis
por: Mansour-Ghanaei, Roxana, et al.
Publicado: (2016)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
por: Brandal, Lin T., et al.
Publicado: (2022)

Evaluation of acellular pertussis vaccine: comparisons among different strains of mice
por: Wei, Jie, et al.
Publicado: (2023)

Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes
por: Aspatwar, Ashok, et al.
Publicado: (2018)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

The Association between Childhood Immunization and Gender Inequality: A Multi-Country Ecological Analysis of Zero-Dose DTP Prevalence and DTP3 Immunization Coverage
por: Vidal Fuertes, Cecilia, et al.
Publicado: (2022)

Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives
por: Hoonakker, Marieke, et al.
Publicado: (2017)

Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization
por: Acquaye-Seedah, Edith, et al.
Publicado: (2018)

Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea
por: Park, Chulmin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lsmv6e8kaj5p19gabojmnrsje2